BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2023 7:45:48 AM | Browse: 429 | Download: 1352
 |
Received |
|
2022-12-19 18:44 |
|
Peer-Review Started |
|
2022-12-19 18:46 |
|
First Decision by Editorial Office Director |
|
2023-02-08 07:34 |
|
Return for Revision |
|
2023-02-08 07:34 |
|
Revised |
|
2023-03-07 17:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-04-04 03:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-04-04 09:00 |
|
Articles in Press |
|
2023-04-04 09:00 |
|
Edit the Manuscript by Language Editor |
|
2023-04-13 22:21 |
|
Typeset the Manuscript |
|
2023-05-17 02:13 |
|
Publish the Manuscript Online |
|
2023-05-19 07:45 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Impact of erythropoietin therapy on cardiorenal syndrome: A systematic review with meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rubal Bhangal, Ivan Cancarevic, Mahmoud Nassar and Zaryab Umar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mahmoud Nassar, MD, MSc, PhD, Doctor, Doctor, Department of Internal Medicine , Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York , NY 10029, United States. dr.nassar@aucegypt.edu |
| Key Words |
Cardiorenal syndrome; Anemia; Cardiovascular disease; End-stage renal disease; Erythropoietin; Congestive heart failure |
| Core Tip |
Erythropoietin improves baseline hemoglobin levels and decreases the risk of major cardiovascular. |
| Publish Date |
2023-05-19 07:45 |
| Citation |
Bhangal R, Cancarevic I, Nassar M, Umar Z. Impact of erythropoietin therapy on cardiorenal syndrome: a systematic review with meta-analysis. World J Cardiol 2023; 15(5): 273-283 |
| URL |
https://www.wjgnet.com/1949-8462/full/v15/i5/273.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v15.i5.273 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
